DeCS Categories
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.847 Polycyclic Aromatic Hydrocarbons .
D02.455.426.559.847.562 Naphthacenes .
D02.455.426.559.847.562.050 Anthracyclines .
D02.455.426.559.847.562.050.200 Daunorubicin .
D02.455.426.559.847.562.050.200.175 Doxorubicin .
D02.455.426.559.847.562.050.200.300 Idarubicin .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.663 Pyrans .
D03.383.663.705 Pyran Copolymer .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.562 Naphthacenes .
D04.615.562.050 Anthracyclines .
D04.615.562.050.200 Daunorubicin .
D04.615.562.050.200.175 Doxorubicin .
D04.615.562.050.200.300 Idarubicin .
D05 Macromolecular Substances .
D05.750 Polymers .
D05.750.830 Pyran Copolymer .
D09 Carbohydrates .
D09.408 Glycosides .
D09.408.051 Aminoglycosides .
D09.408.051.059 Anthracyclines .
D09.408.051.059.200 Daunorubicin .
D09.408.051.059.200.175 Doxorubicin .
D09.408.051.059.200.300 Idarubicin .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.486 Immunoproteins .
D12.776.124.486.485 Immunoglobulins .
D12.776.124.486.485.114 Antibodies .
D12.776.124.486.485.114.224 Antibodies, Monoclonal .
D12.776.124.486.485.114.224.075 Antibodies, Monoclonal, Murine-Derived .
D12.776.124.486.485.114.224.075.785 Rituximab .
D12.776.124.790 Serum Globulins .
D12.776.124.790.651 Immunoglobulins .
D12.776.124.790.651.114 Antibodies .
D12.776.124.790.651.114.224 Antibodies, Monoclonal .
D12.776.124.790.651.114.224.075 Antibodies, Monoclonal, Murine-Derived .
D12.776.124.790.651.114.224.075.785 Rituximab .
D12.776.377 Globulins .
D12.776.377.715 Serum Globulins .
D12.776.377.715.548 Immunoglobulins .
D12.776.377.715.548.114 Antibodies .
D12.776.377.715.548.114.224 Antibodies, Monoclonal .
D12.776.377.715.548.114.224.284 Antibodies, Monoclonal, Murine-Derived .
D12.776.377.715.548.114.224.284.785 Rituximab .
D23 Biological Factors .
D23.050 Antigens .
D23.050.285 Antigens, Neoplasm .
D25 Biomedical and Dental Materials .
D25.720 Polymers .
D25.720.830 Pyran Copolymer .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
J01 Technology, Industry, and Agriculture .
J01.637 Manufactured Materials .
J01.637.051 Biomedical and Dental Materials .
J01.637.051.720 Polymers .
J01.637.051.720.830 Pyran Copolymer .
Terms Synonyms & Historicals Documents LILACS e MDL
Antineoplastic Agents . Anticancer Agents . Antineoplastic Drugs . Antineoplastics . Antitumor Agents . Antitumor Drugs . Cancer Chemotherapy Agents . Cancer Chemotherapy Drugs . Chemotherapeutic Anticancer Agents . Chemotherapeutic Anticancer Drug . Agents, Anticancer . Agents, Antineoplastic . Agents, Antitumor . Agents, Cancer Chemotherapy . Agents, Chemotherapeutic Anticancer . Chemotherapy Agents, Cancer . Chemotherapy Drugs, Cancer . Drug, Chemotherapeutic Anticancer . Drugs, Antineoplastic . Drugs, Antitumor . Drugs, Cancer Chemotherapy . Antineoplastic and Immunosuppressive Agents . Antineoplastics, Immunosuppressives . Substances that inhibit or prevent the proliferation of NEOPLASMS. . 0.35